Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Comments Off on Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
June 22, 2026
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register DEA schedulingSchedule I controlled substancessynthetic…
DEA Places 2-Fluorodeschloroketamine in Schedule I Controlled Substances
Comments Off on DEA Places 2-Fluorodeschloroketamine in Schedule I Controlled Substances
June 9, 2026
The DEA has temporarily placed 2-fluorodeschloroketamine in Schedule I of the Controlled Substances Act, reflecting regulatory action against emerging synthetic ketamine analogs. This DEA Schedule I classification demonstrates the federal approach to…
The House Committee on Dangerous Drugs and Health Advances Medical Cannabis Framework
Comments Off on The House Committee on Dangerous Drugs and Health Advances Medical Cannabis Framework
February 24, 2026
The medical cannabis framework Philippines is advancing aims to establish regulatory systems for qualified patients. This legislative effort supports cannabinoid therapies for conditions like chronic pain and epilepsy. The framework ensures patient…